Radiation for Pigmented Villonodular Synovitis — PVNS and Tenosynovial Tumours
Pigmented villonodular synovitis — now usually called tenosynovial giant cell tumour — is a growth of the joint lining. It is benign. It is not cancer. It is also stubborn: the diffuse form comes back after surgery in a large share of people. Radiotherapy is added to surgery to change that recurrence picture, and that is why an orthopaedic surgeon sends a patient without cancer to a cancer centre.
Medically reviewed by Dr. Gangadhar Vajrala, Radiation Oncologist, MBBS · MD (Radiation Oncology) · MPH · Last reviewed August 2026
- Benign, but locally aggressive — PVNS does not spread to other organs. It grows inside the joint, wears away cartilage and bone around it, and returns if any diseased lining is left behind.
- Radiation is added to surgery, not instead of it — the operation removes the disease that can be reached; the beam is aimed at the microscopic lining left in folds the surgeon cannot safely strip.
- Recurrence is the whole reason — published series report better local control when radiotherapy follows an incomplete or repeated operation. It is intended to lower the odds, not to remove them.
- You are not a cancer patient — the machines sit inside cancer services, so that is where you are sent. PVNS is one of a short list of benign conditions treated with a beam.
on Panel
Survival Rate*
Treated
(800+ reviews)
What Is PVNS, and Why Does It Keep Coming Back?
It is a benign growth of the lining of a joint, a tendon sheath or a bursa, now usually called tenosynovial giant cell tumour. It is not cancer and it does not spread to other organs. It returns because the diffuse form grows through the whole lining, and any lining left behind can regrow.
This is a rare condition, and rarity is part of why people arrive here confused. Most patients have already been told two or three different things — a meniscal tear, inflammatory arthritis, a cyst — before the MRI and the biopsy settle it. By then the joint has often been operated on once, and the word recurrence has already been used. That is the real reason radiotherapy comes up.
Your radiotherapy is delivered at an NABH-accredited partner centre; CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout — including talking to your orthopaedic surgeon, because for this condition the surgery and the beam only work as one plan.
Did you know?
Diffuse tenosynovial giant cell tumour is genuinely rare — published population studies put it at fewer than about ten cases per million people a year, which is why so many patients are misdiagnosed first. It is also one of the very few benign conditions for which international soft-tissue tumour guidance, including that of NCCN and ESMO, discusses radiotherapy as a recognised option after incomplete or repeated surgery rather than as an experimental idea.
When Is Radiotherapy Added to Surgery for PVNS?
After the operation, not instead of it, and not for everyone. It is considered when the diseased lining could not be removed completely, when the diffuse form involves the whole joint, or when the disease has already come back. It normally starts once the surgical wound has healed.
- The diagnosis is settled properly first. MRI, then tissue. A beam is never planned on a scan alone, because several ordinary things swell a knee and only one of them is this.
- Your surgeon decides what surgery can realistically achieve. Keyhole clearance suits limited disease. Diffuse disease in a knee often needs open surgery, sometimes from the front and the back, sometimes in two stages. What was actually removed is the single most useful fact in the whole plan.
- The operation note and the pathology report are read together. Complete removal of localised disease usually needs nothing more. Incomplete removal, diffuse involvement of the joint, or a second or third recurrence is where radiotherapy enters the conversation.
- You meet the radiation oncologist. They examine the joint, review the imaging, explain the total dose, the number of sittings and the effects on the joint, and take your consent. Say at this point if you are pregnant or could be, and mention any previous radiation to that limb.
- Treatment runs as short daily sittings over roughly three weeks. Planning happens first on a CT scan with the limb in the treatment position, often with a simple rest or mould so it sits identically each day. Each sitting takes minutes, you go home afterwards, and you are not radioactive at any point.
Radiotherapy is not the only route, and a good team will say so. Repeat surgery alone is reasonable for some people. Careful watching suits small localised disease that is not causing trouble. Some centres offer an injected radioactive agent placed inside the joint instead of an external beam. For selected diffuse cases that cannot be cleared surgically, a targeted tablet treatment prescribed by a medical oncologist is an option, with its own monitoring and its own side effects. Which of these belongs in your plan is a decision for the team holding your imaging, not one to make from a search result.
Does Radiotherapy Actually Prevent It Coming Back?
It lowers the risk of it coming back. It does not remove that risk, and no honest team will promise otherwise. Diffuse disease returns after surgery alone in a substantial share of people, and published series report better local control when radiotherapy is added after an incomplete or repeated operation.
What the evidence actually is
Small retrospective series and single-institution reviews, not large randomised trials. For a condition this rare that is the honest state of the literature, and it is worth knowing before anyone quotes a figure at you. International soft-tissue tumour guidance from bodies such as NCCN and ESMO lists radiotherapy as an option after incomplete or recurrent resection, rather than as a routine first step for everybody.
What changes your own odds
The pattern of disease, localised or diffuse. The joint involved, because a knee can be cleared far more thoroughly than a hip. How much lining the surgeon could reach. And whether this is a first operation or a third. A knee stripped front and back by an experienced team sits in a different place from a partial keyhole clearance, and the same beam means different things in each.
What it will not do
It will not dissolve disease a surgeon has knowingly left behind as visible bulk. Radiotherapy here is aimed at microscopic remnants in the lining. If a large amount of disease is still sitting in the joint, the answer is usually more surgery or a rethink of the plan, not a beam. It also does not undo cartilage or bone damage that has already happened.
This is what makes PVNS unusual among the benign conditions treated with radiation. For most of them the beam is a small preventive gesture. Here it is aimed at a real, measurable problem — a growth that comes back again and again, and that costs you a working joint each time it does. Radiotherapy is intended to break that cycle. In many patients it does. It is a change in the odds, offered honestly, not a guarantee, and it should always be weighed against what another operation would cost you.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Ask About Radiotherapy Before the Next Operation, Not After the Third One
A CION radiation oncologist will explain when a beam is added to surgery for PVNS, what it does to the joint, and the long-term risks in plain words.
I Do Not Have Cancer. Why Am I at a Cancer Centre?
Because the treatment machines and the medical physicists who plan on them sit inside cancer services. Radiation is a tool, not a diagnosis. PVNS is benign, and being referred for radiotherapy says nothing whatsoever about having cancer. What you receive is a modest dose, aimed at one joint, over a few short weeks.
| What differs | Radiation for cancer | Radiation for PVNS after surgery |
|---|---|---|
| Why it is given | To treat or control a malignant tumour | To lower the chance a benign joint lining regrows |
| Where it is aimed | The tumour and the tissue it may have spread into | The lining of one joint and nothing beyond it |
| Total dose | A high total dose, built up session by session | A modest total dose, well below a full cancer course |
| Length of treatment | Commonly five to seven weeks of daily sittings | Roughly three weeks of short weekday sittings |
| Anything given alongside | Often combined with systemic cancer treatment | Nothing systemic. Your surgeon’s rehabilitation plan only |
| The main thing being protected | Disease control and survival | The joint, and how much it still moves in five years |
| Follow-up | Long-term cancer surveillance | Orthopaedic reviews and periodic MRI of the joint |
You are also not the only person in that waiting room who is there for something benign. A short list of non-cancer conditions is treated with a beam — radiation for Dupuytren contracture in the hand, and radiation to prevent heterotopic ossification after hip surgery, both live around joints exactly like yours.
What Does Radiation Do to the Joint Itself?
The main effect is stiffness. Radiation makes the soft tissue around a joint thicken and tighten over months, so movement can be harder to win back. Skin changes are usually mild and settle. Wound healing is slower if the beam starts too soon, which is why timing is planned around the operation.
During the weeks of treatment
Skin over the treated area may redden, darken, dry or feel tight, usually towards the end of the course. Hair in that patch can thin. Some people notice the joint aching a little more. Fatigue is far milder than in a cancer course, because the treated area is small and nothing systemic is given. Use whatever skin care your team advises rather than choosing something yourself.
Over the following months
Scarring in the soft tissue builds slowly, and with it stiffness. This is the effect that matters most, and it is the one you can influence. Physiotherapy is not optional here and it is not something to stop once the joint feels reasonable. Swelling below the joint can appear if lymph channels sat in the treated area. Report a joint that is losing movement early, not at the next scheduled review.
The long-term risk, stated plainly
Any radiation carries a small risk of a new cancer arising in the treated tissue many years later. For a benign condition that has to be said aloud before you consent. There is no reliable percentage to quote and anyone offering a precise one is guessing. It is weighed far more carefully in younger patients, and in children and teenagers growth plates near the joint need specific thought. Radiation is not given in pregnancy.
If you may need more surgery later
Tell any future surgeon that the joint has been irradiated, and roughly when. Previously treated tissue heals more slowly, which changes how a later procedure — including joint replacement — is planned and timed. Keep your radiotherapy summary with your surgical papers. It is a short document and it is the one people most often cannot find years later when it matters.
None of this is a reason to refuse treatment. It is the trade being made: a stiffer joint and a small long-term risk, weighed against a disease that keeps returning and takes movement away each time it does. Radiation therapy at CION Cancer Clinics explains who plans the treatment and where it is delivered. If anything on this page is being used to talk you out of asking questions, ask them anyway — call 1800 202 8726.
What Should I Ask Before I Agree to It?
Five questions settle almost every PVNS radiotherapy decision. Ask them of the surgeon and the radiation oncologist together, and write the answers down. If a plan cannot survive these questions in plain language, it is not ready for your signature yet.
- Was my disease localised or diffuse, and how much was actually removed? Everything else follows from this one answer.
- What happens if I do nothing more? A clear statement of the recurrence risk you personally face, without a number invented for reassurance.
- What are the alternatives for me? Repeat surgery, careful watching, an injected agent inside the joint or a targeted tablet route — and why this one is being recommended over those.
- What will this joint be like in five years? Ask specifically about stiffness, not just about recurrence.
- What is the total dose, how many sittings, and what will it cost? Costs are indicative, as of August 2026, and should be confirmed against your own plan and insurance cover.
Call your surgical team, or CION on 1800 202 8726, the same day if the surgical wound opens or leaks, if redness spreads outwards from it, if you develop a fever, or if the joint suddenly becomes far more painful, hot or swollen than it was. Those are surgical problems that need looking at now, not at your next physiotherapy appointment.
People Who Came Here for Something That Is Not Cancer
Patients who wanted the whole plan explained before they agreed to it, in language they could actually follow.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Radiotherapy for PVNS — Your Questions Answered
What is pigmented villonodular synovitis, and is it cancer?
It is a growth of the lining of a joint, a tendon sheath or a bursa. It is benign, and it does not spread to other organs the way a cancer does. Doctors now usually call it tenosynovial giant cell tumour. There are two patterns. The localised form is a single nodule, most often in a finger or a small joint, and removing it is usually the end of it. The diffuse form spreads through the whole lining of a joint, most commonly the knee and then the hip, and it is the one that keeps returning. Benign is not the same as harmless. Left alone, diffuse disease wears away cartilage and bone around the joint over years.
When is radiotherapy added to surgery for PVNS?
After the operation, not instead of it, and not for everyone. Surgery to strip out the diseased lining is the main treatment. Radiotherapy is usually considered when the lining could not be removed completely, when the diffuse form involves the whole joint, or when the disease has already come back once or more. It normally starts once the surgical wound has healed, which is a few weeks after the operation rather than the next day. Treatment is given as short daily sittings on weekdays over roughly three weeks. The exact schedule and total dose are written into your plan by the radiation oncologist, and you are entitled to see both before you consent.
Does radiotherapy prevent PVNS coming back?
It lowers the risk of it coming back. It does not remove that risk, and no honest team will promise otherwise. Diffuse tenosynovial giant cell tumour returns after surgery alone in a substantial share of people, and published surgical series report better local control when radiotherapy is added after an incomplete or repeated operation. That is why it is offered at all. What you should not accept is a single number quoted at you as a certainty, because the evidence for a condition this rare comes from small retrospective series rather than large randomised trials. Your own odds depend on the joint, the pattern of disease and how much lining the surgeon could actually reach.
What does radiation do to the joint itself?
The most common effect is stiffness. Radiation makes the soft tissue around a joint thicken and tighten over months, so range of movement can be harder to win back and physiotherapy matters more, not less. The skin over the treated area may darken, dry or feel tight for a few weeks. Swelling below the joint can happen if lymph channels sit in the treated area. Wound healing is slower if the beam starts too soon after surgery, which is why the timing is planned around the operation rather than around a waiting list. In children and teenagers, growth plates near the joint need specific thought before anything is agreed.
I do not have cancer. Why am I being sent to a cancer centre?
Because the treatment machines and the medical physicists who plan on them sit inside cancer services. Radiation is a tool, not a diagnosis, and being referred says nothing whatsoever about having cancer. PVNS is one of a short list of benign conditions treated with a beam, alongside conditions such as Dupuytren contracture of the hand and thyroid eye disease. Your radiotherapy is delivered at an NABH-accredited partner centre; CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout, including speaking to your orthopaedic surgeon so that the surgery and the radiotherapy line up sensibly rather than by accident.
What long-term risks should I hear about before I agree?
Two, and both deserve to be said out loud rather than buried. The first is a permanently stiffer joint, because radiotherapy around a joint can leave lasting scarring in the soft tissue, and in a knee or hip already damaged by the disease that matters. The second is a small risk of a new cancer arising in the treated tissue many years later. There is no reliable percentage to quote for a condition this rare, and anyone who gives you a precise one is guessing. That risk is weighed far more carefully in younger patients. Radiation is not given in pregnancy, so say if you are pregnant or could be.